Comments
Merck osteoporosis drug, company pipeline win more respect
13.07.2012. | (Reuters) - Industry analysts on Thursday predicted annual sales of up to $3 billion for a Merck osteoporosis drug shown to be effective before its clinical trial was completed, and said the development could provide a needed jolt of faith in Merck's overall drugs pipeline....
